MHRA guidance requires that products are labelled 'for research purposes only' and make no medical claims regarding disease treatment or prevention.
Long-term treatment outcome of two patients with pyridoxine-dependent epilepsy caused by ALDH7A1 mutations: normal neurocognitive outcome
Pros: The potential for a more targeted and potent effect is the obvious draw
This includes advice on nutrition, exercise, and stress management, creating a holistic framework that supports long-term success
The manufactured products under investigation are the USP, 30 mL, multi-dose vial, lot W20308
Key takeaways BPC-157 is a peptide derived from a natural stomach protein called Body Protection Compound, which is known for its potential to support the gut barrier